Nanostructured lipid carriers as robust systems for topical lidocaine-prilocaine release in dentistry

European Journal of Pharmaceutical Sciences

Volumn 93, Issue , 2016, Pages 192-202

  Ribeiro, Lígia N M ^a   Franz Montan, Michelle ^a   Breitkreitz, Márcia C ^a   Alcântara, Ana C S ^b   Castro, Simone R ^a   Guilherme, Viviane A ^a   Barbosa, Raquel M ^c   de Paula, Eneida ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Dentistry; Factorial design; Lidocaine; Nanostructured lipid carriers; Prilocaine

Indexed keywords

DECANOIC ACID; DRUG CARRIER; EXCIPIENT; LIDOCAINE; NANOMATERIAL; PRILOCAINE; TRIACYLGLYCEROL; LIPID; LOCAL ANESTHETIC AGENT;

ARTICLE; CENTRIFUGATION; COLLOID; DENTISTRY; DRUG FORMULATION; DRUG RELEASE; LIPID TRANSPORT; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; ULTRAFILTRATION; ZETA POTENTIAL; CHEMISTRY; MEDICINAL CHEMISTRY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANESTHETICS, LOCAL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG LIBERATION; LIDOCAINE; LIPIDS; NANOSTRUCTURES; PRILOCAINE;

EID: 84983400660     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2016.08.030     Document Type: Article

References (77)

1. Abdel-Mottaleb, M.M.A., Neumann, D., Lamprecht, A., In vitro drug release mechanism from lipid nanocapsules (LNC). Int. J. Pharm. 390 (2010), 208–213.
2. 1H NMR). Colloids Surf. B Biointerfaces 77 (2010), 286–297.
3. Andreani, T., Fangueiro, J.F., Jose, S., Santini, A., Silva, A.M., Souto, E.B., Hydrophilic polymers for modified-release nanoparticles: a review of mathematical modelling for pharmacokinetic analysis. Curr. Pharm. Des. 21 (2015), 3090–3096.
4. Aranda, P., Alcântara, A.C.S., Ribeiro, L.N.M., Darder, M., Ruiz-Hitzky, E., Choi, H., Choy, J.H., Lee, U., Varadan, V.K., (eds.) Bionanocomposites based on layered double hydroxides as drug delivery systems, Proccedings SPIE, Nanosystems in Engineering and Medicine 85486D, 2012.
5. Attama, A.A., Momoh, M.A., Builders, P.F., Lipid Nanoparticulate Drug Delivery Systems: A Revolution in Dosage Form Design and Development. Recent Advances in Drug Delivery Systems, 2012, 107–140.
6. Barbosa, R.M., Silva, C.M.G., Bella, T.S., Araújo, D.R., Marcato, P.D., Durán, N., de Paula, E., Cytotoxicity of solid lipid nanoparticles and nanostructured lipid carriers containing the local anesthetic dibucaine designed for topical application. J. Phys. Conf. Ser., 429, 2013, 012035.
7. Basha, M., El-Alim, S.H.A., Kassem, A.A., Awdan, S.E., Awad, G., Benzocaine loaded solid lipid nanoparticles: formulation design, in vitro and in vivo evaluation of local anesthetic effect. Curr. Drug Deliv. 12 (2015), 1–13.
8. Battaglia, L., Gallarate, M., Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Expert Opin. Drug Deliv. 9 (2012), 497–508.
9. Bhagurkar, A.M., Angamuthu, M., Patil, H., Tiwari, R.V., Maurya, A., Hashemnejad, S.M., Kundu, S., Murthy, S.N., Repka, M.A., Development of an ointment formulation using hot-melt extrusion technology. AAPS PharmSciTech 17 (2016), 158–166.
10. Bragagni, M., Maestrelli, F., Mura, P., Physical chemical characterization of binary systems of prilocaine hydrochloride with triacetyl-β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 68 (2010), 437–445.
11. Bunjes, H., Structural properties of solid lipid based colloidal drug delivery systems. Curr. Opin. Colloid Interface Sci. 16 (2011), 405–411.
12. Carr, B., Wright, M., Nanoparticle Tracking Analysis: A Review of Appliations and Usage 2010–2012. 2012.
13. Cereda, C.M.S., Araujo, D.R., Brunetto, G.B., de Paula, E., Liposomal prilocaine: preparation, characterization, and in vivo evaluation. J. Pharm. Pharm. Sci. 7 (2004), 235–240.
14. Chun, M.K., Hossain, K., Choi, S.H., Ban, S.J., Moon, H., Choi, H.K., Development of cataplasmic transdermal drug delivery system containing eutectic mixture of lidocaine and prilocaine. J. Pharm. Investig. 42 (2012), 139–146.
15. Dragovic, R.A., Gardiner, C., Brooks, A.S., Tannetta, D.S., Ferguson, D.J.P., Hole, P., Carr, B., Redman, C.W.G., Harris, A.L., Dobson, P.J., Harrison, P., Sargent, I.L., Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomed.: Nanotechnol., Biol. Med. 7 (2011), 780–788.
16. Dudhipala, N., Veerabrahma, K., Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design. Drug Dev. Ind. Pharm. 41 (2015), 1968–1977.
17. Ekambaram, P., Sathali, A.A.H., Priyanka, K., Solid lipid nanoparticles: a review. Sci. Revs. Chem. Commun. 2 (2012), 80–102.
18. Esposito, E., Ravani, L., Contado, C., Costenaro, A., Drechsler, M., Rossi, D., Menegatti, E., Grandini, A., Cortesi, R., Clotrimazole nanoparticle gel for mucosal administration. Mater. Sci. Eng. C 33 (2013), 411–418.
19. Ferreira, M., Chaves, L.L., Lima, S.A.C., Reis, S., Optimization of nanostructured lipid carriers loaded with methotrexate: a tool for inflammatory and cancer therapy. Int. J. Pharm. 492 (2015), 65–72.
20. Filipe, V., Hawe, A., Jiskoot, W., Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm. Res. 27 (2010), 796–810.
21. Franz-Montan, M., Ranali, J., Ramacciato, J.C., de Andrade, E.D., Volpato, M.C., Groppo, F.C., Ulceration of gingival mucosa after topical application of EMLA: report of four cases. Br. Dent. J. 204 (2008), 133–134.
22. Franz-Montan, M., Baroni, D., Brunetto, G., Sobral, V.R.V., da Silva, C.M.G., Venâncio, P., Zago, P.W., Cereda, C.M.S., Volpato, M.C., Araújo, D.R., de Paula, E., Groppo, F.C., Liposomal lidocaine gel for topical use at the oral mucosa: characterization, in vitro assays and in vivo anesthetic efficacy in humans. J. Lipid Res. 25 (2014), 11–19.
23. Freitas, C., Müller, R.H., Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN®) dispersions. Int. J. Pharm. 168 (1998), 221–229.
24. Gonzalez-Mira, E., Egea, M.A., Souto, E.B., Calpena, A.C., García, M.L., Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology 22 (2011), 1–15.
25. Guimarães, K.L., Ré, M.I., Lipid nanoparticles as carriers for cosmetic ingredients: the first (SLN) and the second generation (NLC). Beck, R., Guterres, S., Pohlmann, A.R., (eds.) Nanocosmetics and Nanomedicines New Approaches for Skin Care, 2011, Springer, 1101–1122.
26. Gupta, B., Poudel, B.K., Tran, T.H., Pradhan, R., Cho, H.J., Jeong, J.H., Shin, B.S., Choi, H.G., Yong, C.S., Kim, J.O., Modulation of pharmacokinetic and cytotoxicity profile of imatinib base by employing optimized nanostructured lipid carriers. Pharm. Res. 32 (2015), 2912–2927.
27. Hazzah, H.A., Farid, R.M., Nasra, M.M.A., Hazzah, W.A., El-Massik, M.A., Abdallah, O.Y., Gelucire-based nanoparticles for curcumin targeting to oral mucosa: preparation, characterization, and antimicrobial activity assessment. J. Pharm. Sci. 104 (2015), 3913–3924.
28. Heurtault, B., Saulnier, P., Pech, B., Proust, J.E., Benoit, J.P., Physico-chemical stability of colloidal lipid particles. Biomaterials 24 (2003), 4283–4300.
29. Ho, H.O., Chen, C.N., Sheu, M.T., Influence of pluronic F-68 on dissolution and bioavailability characteristics of multiple-layer pellets of nifedipine for controlled release delivery. J. Control. Release 68 (2000), 433–440.
30. James, A.E., Driskell, J.D., Monitoring gold nanoparticle conjugation and analysis of biomolecular binding with nanoparticle tracking analysis (NTA) and dynamic light scattering (DLS). Analyst 138 (2013), 1212–1218.
31. Jenning, V., Thünemann, A.F., Gohla, S.H., Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int. J. Pharm. 199 (2000), 167–177.
32. Jensen, L.B., Pavan, G.M., Kasimova, M.R., Rutherford, S., Danani, A., Nielsen, H.M., Foged, C., Elucidating the molecular mechanism of PAMAM-siRNA dendriplex self-assembly: effect of dendrimer charge density. Int. J. Pharm. 416 (2011), 410–418.
33. Karavana, S.Y., Gökçe, E.H., Rençber, S., Özbal, S., Pekçetin, C., Güneri, P., Ertan, G., A new approach to the treatment of recurrent aphthous stomatitis with bioadhesive gels containing cyclosporine A solid lipid nanoparticles: in vivo/in vitro examinations. Int. J. Nanomedicine 7 (2012), 5693–5704.
34. Le, T.T., Saveyn, P., Hoa, H.D., Van der Meeren, P., Determination of heat-induced effects on the particle size distribution of casein micelles by dynamic light scattering and nanoparticle tracking analysis. Int. Dairy J. 18 (2008), 1090–1096.
35. Martins, S., Tho, I., Reimold, I., Fricker, G., Souto, E.B., Ferreira, D., Brandl, M., Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Int. J. Pharm. 439 (2012), 49–62.
36. McMillan, A.S., Walshaw, D., Meechan, J.G., The efficacy of Emla and 5% lignocaine gel for anaesthesia of human gingival mucosa. Br. J. Oral Maxillofac. Surg. 38 (2000), 58–61.
37. Meechan, J.G., Effective topical anesthetic agents and techniques. Dent. Clin. N. Am. 46 (2002), 759–766.
38. Meechan, J.G., Howlett, P.C., Smith, B.D., Factors influencing the discomfort of intraoral needle penetration. Anesth. Prog. 52 (2005), 91–94.
39. Mendes, A.I., Silva, A.C., Catita, J.A.M., Cerqueira, F., Gabriel, C., Lopes, C.M., Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity. Colloids Surf. B Biointerfaces 111 (2013), 755–763.
40. Mendyk, A., Jachowicz, R., Unified methodology of neural analysis in decision support systems built for pharmaceutical technology. Expert Syst. Appl. 32 (2007), 1124–1131.
41. Morales, J.O., Valdés, K., Morales, J., Oyarzun-Ampuero, F., Lipid nanoparticles for the topical delivery of retinoids and derivatives. Nanomedicine 10 (2015), 253–269.
42. Müller, R.H., Rühl, D., Runge, S.A., Biodegradation of solid lipid nanoparticles as a function of lipase incubation time. Int. J. Pharm. 144 (1996), 115–121.
43. Müller, R.H., Mader, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery ± a review of the state of the art. Eur. J. Pharm. Biopharm. 50 (2000), 161–177.
44. Müller, R.H., Radtke, M., Wissing, S.A., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54:Suppl 1 (2002), S131–S155.
45. Müller, R.H., Shegokar, R., Keck, C.M., 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Curr. Drug Discov. Technol. 8 (2011), 207–227.
46. Müller, R.H., Jenning, V., Mader, K., Lippacher, A., Lipid Particles on the Basis of Mixtures of Liquid and Solid Lipids and Methods for Producing the Same US 8,663,692 B1. 2014.
47. Nurkeeva, Z.S., Mun, G.A., Khutoryanskiy, V.V., Bitekenova, A.B., Dzhusupbekova, A.B., Polymeric complexes of lidocaine hydrochloride with poly(acrylic acid) and poly(2-hydroxyethyl vinyl ether). J. Biomater. Sci. Polym. Ed. 13 (2002), 759–768.
48. Nyqvist-Mayer, A.A., Brodin, A.F., Frank, S.G., Drug release studies on an oil-water emulsion based on a eutectic mixture of lidocaine and prilocaine as the dispersed phase. J. Pharm. Sci. 75 (1986), 365–373.
49. Paavola, A., Yliruusi, J., Kajimoto, Y., Kalso, E., Wahlström, T., Rosenberg, P., Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block. Pharm. Res. 12 (1995), 1997–2002.
50. Pardeike, J., Hommoss, A., Müller, R.H., Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 366 (2009), 170–184.
51. Pokharkar, V.B., Jolly, M.R., Kumbhar, D.D., Engineering of a hybrid polymer–lipid nanocarrier for the nasal delivery of tenofovir disoproxil fumarate: physicochemical, molecular, microstructural, and stability evaluation. Eur. J. Pharm. Sci. 71 (2015), 99–111.
52. Puglia, C., Sarpietro, M.G., Bonina, F., Castelli, F., Development, characterization, and in vitro and in vivo evaluation of benzocaine-and lidocaine-loaded. J. Pharm. Sci. 100 (2011), 1892–1899.
53. Rahman, Z., Zidan, A.S., Khan, M.A., Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 76 (2010), 127–137.
54. Rajendiran, N., Mohandoss, T., Saravanan, J., Guest: host interactions of lidocaine and prilocaine with natural cyclodextrins: spectral and molecular modeling studies. Spectrochim. Acta A Mol. Biomol. Spectrosc. 132 (2014), 387–396.
55. Rathore, A.S., Roadmap for implementation of quality by design (QbD) for biotechnology products. Trends Biotechnol. 27 (2009), 546–553.
56. Ribeiro, L.N.M., Alcântara, A.C.S., Darder, M., Aranda, P., Araújo-Moreira, F.M., Ruiz-Hitzky, E., Pectin-coated chitosan-LDH bionanocomposite beads as potential systems for colon-targeted drug delivery. Int. J. Pharm. 463 (2014), 1–9.
57. Ribeiro, L.N.M., Alcântara, A.C.S., Darder, M., Aranda, P., Herrmann, P.S.P., Araújo-Moreira, F.M., García-Hernández, M., Ruiz-Hitzky, E., Bionanocomposites containing magnetic graphite as potential systems for drug delivery. Int. J. Pharm. 477 (2014), 553–563.
58. Riddick, T., Zeta-Meter Manual Inc. 2nd ed., 1968, Zeta, New York.
59. Ritger, P.L., Peppas, N.A., A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Control. Release 5 (1987), 23–36.
60. Roghani, S., Duperon, D.F., Barcohana, N., Evaluating the efficacy of commonly used topical anesthetics. Pediatr. Dent. 21 (1999), 197–200.
61. Rose, F., Wern, J.E., Ingvarsson, P.T., van de Weert, M., Andersen, P., Follmann, F., Foged, C., Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: a quality-by-design approach. J. Control. Release 210 (2015), 48–57.
62. Ryan, S.E., Baenziger, J.E., A structure-based approach to nicotinic receptor pharmacology. Mol. Pharmacol. 55 (1999), 348–355.
63. Sanz, R., Calpena, A.C., Mallandrich, M., Clares, B., Enhancing topical analgesic administration: review and prospect for transdermal and transbuccal drug delivery systems. Curr. Pharm. Des. 21 (2015), 2867–2882.
64. Saupe, A., Gordon, K.C., Rades, T., Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int. J. Pharm. 314 (2006), 56–62.
65. Scherlund, M., Brodin, A., Malmsten, M., Micellization and gelation in block copolymer systems containing local anesthetics. Int. J. Pharm. 211 (2000), 37–49.
66. Schmidt, A.C., Niederwanger, V., Griesser, U.J., Solid-state forms, of prilocaine hydrochloride: crystal polymorphism of local anaesthetic drugs, part II. J. Therm. Anal. Calorim. 77 (2004), 639–652.
67. Schmidt, P., Dybal, J., Šturcová, A., ATR FTIR investigation of interactions and temperature transitions of poly(ethylene oxide), poly(propylene oxide) and ethylene oxide-propylene oxide-ethylene oxide tri-block copolymers in water media. Vib. Spectrosc. 50 (2009), 218–225.
68. Schwarz, C., Mehnert, W., Lucks, J.S., Müller, R.H., Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J. Control. Release 30 (1994), 83–96.
69. 2 full factorial design: effect of homogenization technique. Mater. Sci. Eng. C 32 (2012), 1375–1379.
70. Severino, P., Chaud, M.V., Shimojo, A., Antonini, D., Lancelloti, M., Santana, M.H.A., Souto, E.B., Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: antibiotic resistance tests and HaCat and NIH/3T3 cell viability studies. Colloids Surf. B Biointerfaces 129 (2015), 191–197.
71. Souto, E.B., Wissing, S.A., Barbosa, C.M., Müller, R.H., Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur. J. Pharm. Biopharm. 58 (2004), 83–90.
72. Souto, E.B., Müller, R.H., Gohla, S., A novel approach based on lipid nanoparticles (SLN) for topical delivery of alpha-lipoic acid. J. Microencapsul. 22 (2005), 581–592.
73. Tibbitt, M.W., Dahlman, J.E., Langer, R., Emerging frontiers in drug delivery. J. Am. Chem. Soc. 138 (2016), 704–717.
74. Üner, M., Characterization and imaging of solid lipid nanoparticles and nanostructured lipid carriers. Handbook of Nanoparticles, 2015, 117–141.
75. Verma, D.D., Verma, S., Blume, G., Fahr, A., Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur. J. Pharm. Biopharm. 55 (2003), 271–277.
76. Vippagunta, S.R., Maul, K.A., Tallavajhala, S., Grant, D.J.W., Solid-state characterization of nifedipine solid dispersions. Int. J. Pharm. 236 (2002), 111–123.
77. zur Mühlen, A., Schwarz, C., Mehnert, W., Solid lipid nanoparticles (SLN) for controlled drug delivery- drug release and release mechanism. Eur. J. Pharm. Biopharm. 45 (1998), 149–155.